Overall, we found 103 clinically affected patients with cardiac involvement (and skeletal muscle glycogenosis and myopathy in some cases), who were investigated often along with family members who were carriers of PRKAG2 mutations [195,196,197,198,199,200,201,202,203,204,205]. The gene discussed is PRKAG2; the disease is myopathy.